Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Originally developed for type 2 diabetes, it has shown exceptional results in clinical trials for weight loss
Not too mushy, but definitely not raw
Because no human safety trial for IGF-1 LR3 exists, risk assessment must be extrapolated from the pharmacology of native IGF-1 and from the mechanism of IGF1R activation
However, with patent expiries, legal developments, and evolving regulatory pathways in India, the market is gradually opening up for broader competition
A healthy rate of weight loss on GLP-1s is about one to two pounds per week, with many people reaching five to ten percent of their starting body weight lost over three to six months
US$ 24.97
US$ 27.48
US$ 24.68
US$ 24.36
US$ 26.98
